Symtomax

Symtomax is a European healthcare company specializing in the cultivation, research, and development of medical cannabis and cannabinoid-based delivery systems. The company is best known for its proprietary Symtostix technology, an oral thin film (OTF) delivery platform designed to provide precise dosing and improved bioavailability of cannabinoids compared to traditional methods. Symtomax operates a large-scale cultivation facility in Portugal, leveraging the region's climate for high-quality, pharmaceutical-grade production. Their product portfolio targets therapeutic areas such as chronic pain, anxiety, and various neurological disorders. By integrating agricultural expertise with advanced manufacturing, Symtomax aims to standardize medical cannabis treatments for the global market. The company holds one of the largest medical cannabis cultivation licenses in Europe, covering approximately 95 hectares in the Alentejo region of Portugal.